| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Customer Service > Beta Means Never Having to Say You're Sorry |
|
Main Subject - Beta Means Never Having to Say You're Sorry
I recently heard a technology presentation from a young but experienced CEO of a big ‘cl According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product icks and mortar’ organization. He told the large audience confidently, ‘Beta means never ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in having to say you’re sorry.’ ‘That’s right,’ I thought to myself. ‘When launching the b lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ta test of a new web-enabled process, customers must understand it’s only a pilot run an here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe should be forgiving if things mess up or don’t work out as planned.’ I was totally wro d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro g about his point of view. In direct contrast to my thinking, this e-commerce veteran e ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc plained that new web-based interactions often do not work properly during a beta test. easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi However, from the customer’s point of view, he insisted, your pilot run must be successf nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically l enough to avoid creating negative customer perceptions or the need to apologize after and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ he fact. The cost and consequences of doing it badly are customer skepticism, hesitatio ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi and negative word-of-mouth. That’s a cost too high to pay in today’s fast-moving world ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a f instant communications. Key Learning Point ------------------------------ dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ------------------------------------------------- If you are planning the des cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin gn and launch of a new customer interface or web-enabled process, be sure to have enough tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen staff and resources on hand to execute brilliantly from the customer's point of view, e t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel en if the technology itself proves problematic. Action Steps -------------- ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ----------------------------------------------------------------- Plan ahead, y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products staff up and allocate more resources than you will require. When you do launch, do whate . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de er it takes to create a positive customer experience. Keep your breakdowns and learning elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ehind the scenes. Make sure your customer is well satisfied and well served out in front tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Construction Job Costing for Profit Medical Transcription - Terminology and Training Call Center Software Downloads
|